CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Sep. 30, 2018	Jun. 30, 2018
Current Assets:
Cash and cash equivalents	$ 580,594	$ 612,057
Marketable securities	4,941	26,745
Accounts receivable, net of allowances of $0 at September 30, 2018 and June 30, 2018, respectively	0	46
Other current assets	8,479	9,532
Total current assets	594,014	648,380
Property and equipment, net of accumulated depreciation of $31,449 thousand and $30,858 thousand at September 30, 2018 and June 30, 2018, respectively	18,587	15,733
Other long-term assets	61	60
Total Assets	612,662	664,173
Current Liabilities:
Accounts payable and accrued expenses	33,710	31,664
Liability related to sale of future royalties - current	4,482	3,009
Warrant liabilities	5,979	8,973
Deferred revenues	0	94
Total current liabilities	44,171	43,740
Convertible senior notes, net	19,799	19,763
Liability related to sale of future royalties - non-current	207,280	198,998
Other long-term liabilities	2,097	1,986
Total Liabilities	273,347	264,487
Commitments and Contingencies (Note 11)
Stockholders' Equity:
Common stock, $0.1 par value; shares authorized 250,000 thousand; shares issued 187,143 thousand and shares outstanding 187,079 thousand at September 30, 2018; shares issued 186,801 thousand and shares outstanding 186,766 thousand at June 30, 2018	1,871	1,868
Capital contributed in excess of par	1,203,025	1,194,998
Treasury stock, at cost: 64 thousand shares at September 30, 2018 and 35 thousand shares at June 30, 2018	(1,092)	(458)
Accumulated deficit	(859,717)	(795,548)
Accumulated other comprehensive loss	(334)	(353)
Total Immunomedics, Inc. stockholders' equity	343,753	400,507
Noncontrolling interest in subsidiary	(4,438)	(821)
Total stockholder's equity	339,315	399,686
Total Liabilities and Stockholders' Equity	$ 612,662	$ 664,173

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.